Buy Pacira Pharmaceuticals Stock | PCRX Stock Price & Latest News | Public.com
PCRX

Pacira Pharmaceuticals

$0.00 (0.00%)Today
    View Pacira Pharmaceuticals (PCRX) stock trends here

    About PCRX

    Pacira Biosciences, Inc. develops and manufactures injectable therapeutic products. The firm engages in the development, commercialization and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its fl...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    2.94
    1.9
    0.87
    -0.17
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $0.66

    Actual EPS
    Q1 2021

    Stats

    Market Cap$3,29B
    Volume461,4k
    Price-to-Earnings Ratio26.74
    Dividend Rate
    Dividend Yield
    1 Year High$79.98
    1 Year Low$27.46
    Open$78.54
    High$80.00
    Low$73.30

    Buy any stock with any amount of money.

    Download the App
    Download the app